Eisai’s Antiepileptic Drug Fycompa Injection Formulation Launched In Japan

Posted by | Apr 18, 2024 | |

TOKYO, Apr 17, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today that the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (IV) infusion has been launched in Japan. The injection formulation of Fycompa received manufacturing and marketing approval on January 18…

Read More